4 | EBML 213% v43,5M c.0188 f512,6M H.0205 BO1 got | znewcar1 | 07/27/2022 6:36:17 PM |
3 | EBML 114% v12,4M c.0075 f512,6M H.0078 ML.0031 | znewcar1 | 06/09/2022 5:43:55 PM |
2 | Low float company, Gold and Silver Exchange in | dahhunter | 07/15/2020 12:36:10 AM |
1 | Thomas E. Puzzo added as counsel Friday July 10th | dahhunter | 07/15/2020 12:34:34 AM |
Recent Articles
- Columbus A/S Share Buyback Update and Overview
- Cognizant Partners with AP Pension for Strategic Growth
- Impact of Federal EV Subsidy Changes on Tesla and Investors
- Broadcom's Promising Future: Growth Powered by AI Partnerships
- Investigation of PubMatic and Class Action Suit Options
- Nutex Health Inc.: Investors' Chance to Join Potential Class Action
- Seeking Justice: Fly-E Group, Inc. Investors Unite for Class Action
- Tronox Holdings Faces Lawsuit: An Investor's Perspective
- Nobel Laureate Inspires at Sustainable Global Leaders Gathering
- Municipality Finance Expands Offerings with New EUR 50M Bond Tap
- NORBIT Secures Significant NOK 120M Defence Order
- CMB.TECH Achieves Fleet Expansion and Revenue Growth
- CMB.TECH NV Initiates Fixed Income Investor Engagements
- JSBC Launches Books Showcasing Chinese Culture and Wisdom
- dsb.net UK Expands Leadership Team to Boost Growth Strategy
- Exciting Halloween Update for My Talking Tom Friends Revealed
- Understanding Foster Care Through the Lens of Resilience
- Cognizant to Empower AP Pension with Innovative Solutions
- CHINT Electric: Pioneering Efficient Solutions for Industry
- Discover Medela's Motion InBra™: Revolutionizing Breast Pumping
- Municipality Finance Strengthens Position With New SEK 1B Note
- Aspocomp's Upcoming Interim Report Highlights Growth Potential
- CMB.TECH Continues Fleet Revitalization Amid Market Fluctuations
- CMB.TECH NV: Series of Fixed Income Investor Meetings Announced
- Chery Unveils Transformable Multi-SUV at Global Brand Night
- Transgene and BioInvent's BT-001 Demonstrates Progress in Cancer Therapy
- AlphaMedix Data Shows Promising Results for Rare Cancer Treatment
- Soitec and CEA Innovate Advancements in Automotive Cybersecurity
- Celebrating Cultural Heritage: Highlights from the Liangzhu Forum
- Breakthrough in Urothelial Carcinoma Treatment at ESMO Congress 2025
- Investa Expands Horizons with New Crowdcube Fundraising Venture
- IO Biotech Unveils Phase 3 Findings on Cylembio and KEYTRUDA
- AlphaMedix Phase 2 Study Highlights Transformative Potential
- AlphaMedix Phase 2 Study Reveals Hope for GEP-NET Treatment
- BT-001 Shows Promise in Advanced Solid Tumors Alongside Therapy
- Innovative Solutions in Automotive Cybersecurity via FD-SOI
- Key Insights on Debtor Distribution Data for Investors
- Nykredit Realkredit A/S Publishes Important Debtor Data
- Recent Progress in US-South Korea Tariff Negotiations Explained
- Understanding Nvidia's Energy Challenge Amid AI Advancements
- Navigating the Class Action for MoonLake Immunotherapeutics
- Investors Encouraged to Join Lawsuit Against Quanex Building Products
- Liquid Wind Marks Major Milestone for eFuel Production Facility
- Chung Kisun Elevated to Chairman of HD Hyundai Leadership
- Nordic Fusion Energy Development: Future Prospects and Locations
- EXEED's Texxeract Technology Unveiled with New Model Designs
- Effective Immunotherapy Approaches for Aggressive Skin Cancer
- VAALCO Energy Announces Upcoming Earnings Conference Details
- MILESEEY Golf’s Innovative GenePro G1 Rangefinder Shines Bright
- Chery's Ride Green Life: A Step Towards Global Sustainability